Considering that a key marker of ccRCC is the inactivating mutation of VHL, leading to the accumulation of HIF-1/2α and reprogramming of tumor metabolism [27], we examined the effect of DMF on HIF-1/2α. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.